ATE469169T1 - Erythrovirus und ihre verwendung - Google Patents

Erythrovirus und ihre verwendung

Info

Publication number
ATE469169T1
ATE469169T1 AT98958322T AT98958322T ATE469169T1 AT E469169 T1 ATE469169 T1 AT E469169T1 AT 98958322 T AT98958322 T AT 98958322T AT 98958322 T AT98958322 T AT 98958322T AT E469169 T1 ATE469169 T1 AT E469169T1
Authority
AT
Austria
Prior art keywords
erythrovirus
sequences
fragments
methods
relates
Prior art date
Application number
AT98958322T
Other languages
English (en)
Inventor
Quang Nguyen
Antoine Garbarg-Chenon
Veronique Auguste
Original Assignee
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE469169T1 publication Critical patent/ATE469169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98958322T 1997-12-03 1998-12-03 Erythrovirus und ihre verwendung ATE469169T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715197A FR2771751B1 (fr) 1997-12-03 1997-12-03 Erythrovirus et ses applications
PCT/FR1998/002615 WO1999028439A2 (fr) 1997-12-03 1998-12-03 Erythrovirus et ses applications

Publications (1)

Publication Number Publication Date
ATE469169T1 true ATE469169T1 (de) 2010-06-15

Family

ID=9514085

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98958322T ATE469169T1 (de) 1997-12-03 1998-12-03 Erythrovirus und ihre verwendung

Country Status (12)

Country Link
US (2) US7291452B1 (de)
EP (1) EP1037916B1 (de)
JP (1) JP4831864B2 (de)
AT (1) ATE469169T1 (de)
AU (1) AU757453B2 (de)
CA (1) CA2311297C (de)
DE (1) DE69841687D1 (de)
DK (1) DK1037916T3 (de)
ES (1) ES2348203T3 (de)
FR (1) FR2771751B1 (de)
PT (1) PT1037916E (de)
WO (1) WO1999028439A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771751B1 (fr) * 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6642033B1 (en) * 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
WO2003020742A1 (en) 2001-08-31 2003-03-13 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
EP2251441B1 (de) 2004-02-10 2013-05-08 F. Hoffmann-La Roche AG Neue Primer und Sonden zur Detektion von Parvovirus B19
US20060057643A1 (en) * 2004-09-10 2006-03-16 Mccarthy Laurence R Methods and compositions for detecting erythrovirus genotypes
WO2006137939A2 (en) 2004-11-09 2006-12-28 Gen-Probe Incorporated Compositions and methods for detecting group a streptococci
WO2007096199A2 (en) * 2006-02-22 2007-08-30 Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh Differential diagnostics and therapy of virally induced heart muscle disease
CA2673770A1 (en) 2007-01-16 2008-07-24 Talecris Biotherapeutics, Inc. Human erythrovirus
WO2009038840A2 (en) * 2007-06-14 2009-03-26 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
EP3257859B1 (de) 2009-02-26 2020-09-23 Gen-Probe Incorporated Assay zum nachweisen menschlicher parvoviren-nukleinsäure
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
AU2011276328C1 (en) 2010-07-06 2016-01-21 Novartis Ag Norovirus derived immunogenic compositions and methods
EP3009522B1 (de) 2011-07-15 2019-09-04 Gen-Probe Incorporated Verfahren zum nachweis von hepatitis-a-virus-nukleinsäuren bei single-plex- oder multiplextests

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7966987A (en) * 1986-09-08 1988-04-07 Applied Biotechnology, Inc. Empty viral capsid vaccines
JP2755817B2 (ja) * 1988-11-14 1998-05-25 アメリカ合衆国 パルボウイルスキャプシド
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6204044B1 (en) * 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
US6379885B1 (en) * 1989-09-14 2002-04-30 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
DE4003826C2 (de) 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
US6274307B1 (en) * 1990-02-08 2001-08-14 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active peptides or polypeptides from the parvovirus B19
JPH07147986A (ja) * 1992-09-24 1995-06-13 Denki Kagaku Kogyo Kk ヒトパルボウイルス遺伝子、それによってコ−ドされるポリペプチド及び用途
AU3698595A (en) * 1994-09-22 1996-04-09 Hans Wolf Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
DE10030677A1 (de) 2000-02-15 2001-08-16 Peter Hechler Schuhwerk mit einer Decksohle
US6668044B1 (en) 2000-07-19 2003-12-23 Xtend Communications Corp. System and method for recording telephonic communications

Also Published As

Publication number Publication date
CA2311297A1 (fr) 1999-06-10
WO1999028439A3 (fr) 1999-07-22
US7291452B1 (en) 2007-11-06
CA2311297C (fr) 2012-10-02
US20080248528A1 (en) 2008-10-09
JP2001525163A (ja) 2001-12-11
FR2771751B1 (fr) 2000-05-26
AU1440399A (en) 1999-06-16
PT1037916E (pt) 2010-08-30
EP1037916B1 (de) 2010-05-26
WO1999028439A2 (fr) 1999-06-10
DE69841687D1 (de) 2010-07-08
ES2348203T3 (es) 2010-12-01
EP1037916A2 (de) 2000-09-27
AU757453B2 (en) 2003-02-20
JP4831864B2 (ja) 2011-12-07
DK1037916T3 (da) 2010-09-27
FR2771751A1 (fr) 1999-06-04
US8105610B2 (en) 2012-01-31

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ATE469169T1 (de) Erythrovirus und ihre verwendung
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR200001835T2 (tr) Aşı.
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
HUP9900813A2 (hu) Továbbfejlesztett kontrasztanyagok
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
BR0214787A (pt) Compósitos elastoméricos, combinações de elastÈmeros e métodos
EA200200565A1 (ru) Применение клеток, трансфицированных днк, кодирующей лиганд мнс класса ii, и способ получения таких клеток
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ATE369429T1 (de) Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
WO2002072787A3 (en) Telomerase expression repressor proteins and methods of using the same
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
EP0826764A3 (de) Verwendung substituierter 2-Acetylbenzofurane als Riechstoffe
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2003000916A3 (en) Telomerase expression repressor proteins and methods of using the same
DE69809930D1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ID23784A (id) Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037916

Country of ref document: EP